S

Sam-A Pharm Co Ltd
KOSDAQ:009300

Watchlist Manager
Sam-A Pharm Co Ltd
KOSDAQ:009300
Watchlist
Price: 16 300 KRW -0.31% Market Closed
Market Cap: 103.8B KRW

Intrinsic Value

The intrinsic value of one Sam-A Pharm Co Ltd stock under the Base Case scenario is 13 849.11 KRW. Compared to the current market price of 16 300 KRW, Sam-A Pharm Co Ltd is Overvalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
13 849.11 KRW
Overvaluation 15%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
Sam-A Pharm Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Sam-A Pharm Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Sam-A Pharm Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Sam-A Pharm Co Ltd.

Explain Valuation
Compare Sam-A Pharm Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Sam-A Pharm Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sam-A Pharm Co Ltd

Current Assets 125.3B
Cash & Short-Term Investments 79.7B
Receivables 26.9B
Other Current Assets 18.7B
Non-Current Assets 123.6B
Long-Term Investments 67.1B
PP&E 40.6B
Intangibles 4.8B
Other Non-Current Assets 11.1B
Current Liabilities 19.2B
Accounts Payable 4.9B
Other Current Liabilities 14.3B
Non-Current Liabilities 5.6B
Long-Term Debt 3.6B
Other Non-Current Liabilities 2B
Efficiency

Free Cash Flow Analysis
Sam-A Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sam-A Pharm Co Ltd

Revenue
82.5B KRW
Cost of Revenue
-31.8B KRW
Gross Profit
50.8B KRW
Operating Expenses
-35.9B KRW
Operating Income
14.9B KRW
Other Expenses
453.7m KRW
Net Income
15.3B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Sam-A Pharm Co Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Sustainable 3Y Average Operating Margin
Healthy Operating Margin
53/100
Profitability
Score

Sam-A Pharm Co Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Sam-A Pharm Co Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
85/100
Solvency
Score

Sam-A Pharm Co Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Sam-A Pharm Co Ltd

There are no price targets for Sam-A Pharm Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Sam-A Pharm Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Sam-A Pharm Co Ltd stock?

The intrinsic value of one Sam-A Pharm Co Ltd stock under the Base Case scenario is 13 849.11 KRW.

Is Sam-A Pharm Co Ltd stock undervalued or overvalued?

Compared to the current market price of 16 300 KRW, Sam-A Pharm Co Ltd is Overvalued by 15%.

Back to Top